Skip to main content
Epistemic AI

Solutions

Analysis for your
next decision.

Competitive landscapes, target product profiles, and conference intelligence. Our AI agents and scientists work together to deliver analysis tailored to your decision.

Complete analysis Sources traceable Scientist reviewed Scheduled updates available

Available today

What each analysis answers, includes, and delivers.

Dashboards, reports, executive decks, and structured data are delivery formats. The analysis is what you purchase.

Competitive intelligence

Competitive landscapes

Epistemic AI's competitive landscapes provide scientist-reviewed analysis of competitors, assets, clinical programs, catalysts, evidence gaps, and implications for portfolio decisions.

Decision
Where should we place the next portfolio bet, and what could change that choice?
Evidence included
Asset and company records, clinical programs, trial data, catalysts, regulatory sources, and market evidence.
What you receive
Competitive landscape, asset profiles, trial matrix, gap analysis, strategic implications, and evidence register.
Available formats
Interactive dashboard, report, executive deck, and structured output.
Update model
Scheduled updates on an agreed cadence.
Illustrative competitive landscape excerpt: patient attrition between lines of therapy in one US real-world cohort, shown as percentage bars.
See the real-world patterns behind the opportunity.

Product strategy

Target product profiles

Epistemic AI's target product profile analysis builds an evidence-backed product strategy connecting the target profile to competitive benchmarks, standards of care, positioning choices, and strategic options.

Decision
How should the asset differentiate, and which profile can the evidence support?
Evidence included
Current and future standards of care, competitor profiles, endpoints, trial designs, regulatory context, and market evidence.
What you receive
Structured TPP, competitive benchmarks, positioning analysis, evidence appendix, and strategic options.
Available formats
Structured profile, interactive dashboard, report, executive deck, and structured data.
Update model
Scheduled updates on an agreed cadence.
Illustrative target product profile excerpt: benchmark cards comparing reported symptom-control gains for two Parkinson's disease therapies.
Clinical benchmarks that make differentiation concrete.

Evidence intelligence

Conference intelligence

Epistemic AI's conference intelligence is an ongoing program that turns high-volume scientific and medical information into conference readiness, evidence updates, and implications your team can use.

Decision
What changed, which signals matter, and how should our positioning or priorities respond?
Evidence included
Abstracts, posters, presentations, trial records, competitor updates, regulatory events, and publications.
What you receive
Conference readiness pack, SWOT analysis, executive summary, evidence update, and post-conference implications.
Available formats
Interactive dashboard, evidence register, report, executive briefing, and structured output.
Update model
Managed across the agreed conference calendar.
Illustrative conference intelligence excerpt: two deal cards with fictional company names, deal values, and strategic rationale.
Keep the competitive picture current as new evidence and deals emerge.

Choose the starting point

Match your question to the analysis.

Buyer question Strategic analysis Included outputs Update model
Where should we place the next portfolio bet? Competitive landscape Asset profiles, trial matrix, implications Agreed cadence
How should the asset differentiate? Target product profile Benchmarks, positioning, strategic options Agreed cadence
What changed at the conference? Conference intelligence Readiness pack, update, executive summary Conference cycle
Where is the trial landscape moving? Clinical trial analysis Trial landscape, comparator matrix, trends Agreed cadence
What does the evidence support? Systematic literature review Search record, extraction table, synthesis Refresh when scoped
Who is shaping the field? KOL mapping Expert landscape, influence map, profiles Agreed cadence

Alone or within a program

Six more analyses for the questions around a decision.

Trial intelligence

Clinical trial analysis

A structured view of active and completed trials designed to expose changes in development strategy and competitive risk.

Decision
Where is the trial landscape moving, and which changes could affect our program?
Can include
Trial designs, endpoints, and eligibility criteria; enrollment, progress, outcomes, and safety signals; sponsor, asset, indication, and biomarker relationships; cross-program and cross-therapy trends.
Formats
Trial landscape, comparator matrix, trend analysis, evidence register, and strategic implications.

Discuss a trial analysis

Clinical-trial records and endpoint comparison tables in an Epistemic research view.
Illustrative research view. Client analyses are scoped to each question.

Profiles

Company, asset, drug, and target profiles

Connected profiles assemble the evidence around an entity and make it comparable across a landscape or portfolio.

Decision
What do we know about this company, asset, drug, or target, and what matters for the decision?
Can include
Pipeline, mechanism, indication, and development stage; clinical programs, catalysts, outcomes, and evidence; company, partner, target, and competitor relationships; relevant patents, regulatory context, and source links.
Formats
Structured profiles, comparative matrices, evidence appendix, and executive summary.

Discuss a profile

Linked company, drug, disease, and clinical-trial profiles in an Epistemic research view.
Illustrative research view. Client analyses are scoped to each question.

Expert landscapes

KOL mapping and expert profiles

A mapped view of the key opinion leaders, investigators, and experts shaping a therapeutic area, connected to the evidence behind their work.

Decision
Who is shaping the field, what is their expertise, and how are they connected?
Can include
Principal investigators and academic or industry experts; publications, trials, patents, and institutional roles; therapeutic-area focus and evidence contribution; collaboration and influence networks.
Formats
Expert landscape, influence map, structured profiles, prioritization framework, and evidence register.

Discuss KOL mapping

Expert search results and an influence network in an Epistemic research view.
Illustrative research view. Client analyses are scoped to each question.

Evidence review

Systematic literature reviews

A scoped, source-linked review of the scientific record focused on the evidence, uncertainty, and implications relevant to a strategic question.

Decision
What does the evidence support, where does it conflict, and which gaps could change the conclusion?
Can include
Scientific literature and trial records; source screening, extraction, and evidence tables; contradictions, uncertainties, and evidence gaps; links among targets, mechanisms, assets, and outcomes.
Formats
Evidence review, source-linked narrative, evidence table, gap analysis, and strategic implications.

How we run a literature review Discuss a review

Linked gene, drug, variant, and literature evidence in an Epistemic research view.
Illustrative research view. Client analyses are scoped to each question.

Opportunity assessment

Opportunity and target assessments

An evidence-backed assessment of target or opportunity hypotheses, designed to make comparative strengths, risks, and unknowns explicit.

Decision
Which opportunities merit deeper investigation, and what evidence strengthens or weakens each hypothesis?
Can include
Target biology, disease relevance, and tractability; drug, mechanism, indication, and competitor activity; clinical, translational, and safety evidence; evidence gaps, risks, and differentiating factors.
Formats
Opportunity landscape, target profiles, prioritization framework, evidence gaps, and strategic options.

Discuss an assessment

Drug, target, indication, and interaction comparisons in an Epistemic research view.
Illustrative research view. Client analyses are scoped to each question.

Managed over time

Keep the analysis current.

We agree the cadence with your team. Epistemic incorporates new evidence, life-science experts review the changes, and the work is updated for the next decision cycle.

  1. 01Initial analysis provided
  2. 02New evidence gathered for the agreed review
  3. 03Scientists inspect changes and implications
  4. 04Updated analysis provided
Scheduled updates sequence from strategic question to scientist-reviewed analysis and agreed update cycle.

The platform

Every analysis builds on connected evidence.

Our knowledge graph already connects more than 10 billion nodes of biomedical evidence. What we gather for one question stays connected, so the next asset, indication, or scenario starts from it instead of from scratch.

See the platform

Connected evidence foundation Gather once. Connect over time.
More assets More indications More scenarios More hypotheses

Your next decision starts here

What decision is
your team facing?

Bring us your question. We reply within one business day and help define the analysis that moves you forward.

Talk to our team